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During the past decade three types of antipoliomyelitie sera have 
been employed in the therapy of acute anterior poliomyelitis.  These 
are, first, the sera of convalescent human poliomyelitis; second, sera 
from horses immunized against the streptococci supposed by Rosenow 
and others (1-12)  to be etiologically related to poliomyelitis; third, 
the Pettit serum prepared at the Pasteur Institute  (13).  The last 
mentioned product  consists of  sheep  serum  or  horse  serum  from 
animals  supposedly immunized against poliomyelitis virus through 
repeated intravenous injections of emulsions of spinal cords of poli- 
omyelitic monkeys.  The experimental evidence upon which Rosenow 
and his coworkers base their claims  for  the  efficacy of anfistrepto- 
coccus poliomyelitis serum  is  discussed in another paper (14)  and 
need not receive further mention at  this moment.  As regards the 
antipoliomyelitic serum of Pettit, it is sufficient to say that, so far as 
can be determined, the experimental evidence for its therapeutic value 
rests upon a  single neutralization experiment of somewhat doubtful 
significance, as we  shall later show.  Since both the Rosenow and 
Pettit's serums have been more or less widely employed,  it was deemed 
desirable to study this neutralizing action on the virus of poliomye- 
litis. 
Amoss and Eberson (20) have already made a series of neutralizing tests with the 
Rosenow serum and failed to detect neutralizing properties.  The Pettit serumwas 
originally  prepared from sheep'"immunized" by intravenous injection with sus- 
pensions  of  poliomyelitic  monkey  cords.  Later, "immune"  horse  serum  was 
produced by a similar procedure (15).  As previously mentioned, only one neutral- 
ization experiment is recorded.  Two monkeys, A and B, received intracerebraUy 
virus plus "immune"  sheep  serum and virus alone respectively.  The monkey 
with the serum-virus mixture  remained normal, but the monkey receiving virus 
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alone developed typical poliomyelitis.  Since occasional neutralization of polio- 
myelitis virus by sheep sera is not at all unknown  in this laboratory (21), we were 
inclined to suspect that the apparent favorable result obtained by Pettit rested 
upon some such chance neutralization; this was more probable since in the  ex- 
periment reported the  control neutralization set  up  was made with virus alone 
instead of with a mixture of virus plus "normal" sheep serum.  This is an unsafe 
procedure  in  testing a  heterologous serum.  For  this  occasional virus neutral- 
ization by sera of non-susceptible animals, no immediate explanation is apparent. 
TABLE  I. 
Series I. 
Monke 
1 
Intraccrebral inocu|um 
Pettit antipoliomyelitis serum .............  0.9 cc. 
5% Berkefdd filtrate poliomyelitis virus  ....  0.3 cc. 
Rosenow anfipoliomyelitis serum concen- 
trated (Eli Lilly) .......................  0.9 cc. 
5% Berkefeld filtrate poliomyelitis virus ....  0.3 cc. 
Human  convalescent serum a ..............  0.9  cc. 
5%  Berkefeld filtrate poliomyelitis virus ....  0.3  cc. 
Human convalescent serum b  ..............  O. 9 cc. 
5% Berkefeld filtrate poliomyelitis virus  ....  0.3 cc. 
Normal horse serum ......................  0.9  cc. 
5% Berkefeld filtrate poliomyelitis virus  ....  0.3 cc. 
Normal human serum ....................  0.9 cc. 
5% Berkefeld filtrate poliomyelitis virus  ....  0.3 cc. 
Result* 
Typical  poliomyelitis 
Typical poliomyelitis 
Remained well 
Remained well 
Typical poliomyelitis 
Abortive poliomyelitis 
* Confirmed by histological study. 
Numerous clinical papers  (15-19)  are available, showing the supposed bene- 
ficial effect of the Pettit serum in the arrest of human poliomyelitis.  In none is it 
possible for an unbiased reader to ascertain any certain evidence that the bene- 
ficial results attained were really due to the serum therapy.  In fact, certain favor- 
able results are  claimed in late paralyzed cases  well beyond the period of acute 
disease  and even in ~ases  of  myelitis certainly clinically of  non-poliomyelitic 
variety. 
The experiments to  be reported  in the present paper  are  several. 
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Macacus rhesus monkeys were used as experimental animals.  The poliomye- 
litis virus serving for infection was the Rockefeller  Institute M.A. strain.  The 
Rosenow serum was obtained from  Eli Lilly and  Company,  the  Pettit  serum 
through the kindness of Dr. A. Pettit; a  similar serum was later prepared by us 
in accordance  with  Pettit's  original published  method.  As  control  sera  we 
employed those of convalescent humans,  convalescent monkeys, normal monkeys, 
normal horse, and normal sheep.  The sera to be tested were mixed with  either 
suspensions or  Berkefeld filtrates of fresh  virus, were  incubated 2  hours,  and 
allowed to stand overnight in the ice box.  All animals were etherized and infected 
TABLE  II. 
Series II. 
Monke 
7 
10 
11 
12 
Intracerebral inoculum  Result 
Pettit antipoliomyelitis serum .............  0.9 cc. 
5% Berkefeld filtrate poliomyelitis virus  ....  0.3 cc. 
Rosenow antipoliomyelitis serum unconcen- 
trated (Eli Lilly) ......................  0.9 ce. 
5~ Berkefeld filtrate poliomyelitis virus  ....  0.3 cc. 
Human convalescent serum ................  0.9 cc. 
5~ Berkefeld filtrate poliomyelitis virus  ....  0.3 cc. 
Monkey convalescent serum ...............  0.9 cc. 
5% Berkefeld filtrate poliomyelitis virus  ....  0.3 cc. 
Normal horse serum ......................  0.9 cc. 
5% Berkdeld filtrate poliomyelitis virus  ....  0.3 cc. 
Normal monkey serum ...................  0.9 cc. 
5% Berkefeld filtrate poliomyelitis virus ....  0.3 cc. 
Remained well 
Typical poliomyelitis 
Remained well 
Remained well 
Typical poliomyelitis 
Typical poliomyelitis 
intracerebrally.  The results are best shown by Tables I  to VI.  We are con- 
cemed only with the development of definite paralytic poliomyelitis  and not with 
the question of death or survival, degree of  paralyses,  or length of incubation 
periods.  In small series these are deemed of doubtful significance. 
It is  evident from  the  three  series of  experiments summarized in 
Tables I  to III that no virus neutralizations  have occurred with Rose- 
now's  serum--at  least  with  the  three  different  samples  employed. 
The  Pettit  serum  has  neutralized,  but  the  neutralization was  in- 
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suspension  rather  than  a  Berkefeld  filtrate.  Pettit  utilized  suspen- 
sions in his own  neutralization  tests.  Further  results  with  both  sus- 
pension  and filtrate appear  in Table  IV.  It is quite apparent  that  the 
Pettit  serum  does not consistently  neutralize  virus. 
TABLE  llI. 
Series HI. 
Monkey  Intracerebral inoculum  Result 
13 
14 
15 
Rosenow autipoliomyelitis serum ...........  0.9 cc. 
5% Berkefeld filtrate poliomyelitis virus ....  0.3 cc. 
Pettit antipoliomyelitis serum .............  0.9 cc. 
5% Berkefeld filtrate poliomyelitis virus ....  0.3 cc. 
Normal horse serum ......................  O. 9 cc. 
5% Berkefdd filtrate poliomyelitis virus ....  0.3 cc. 
Typical poliomyelitis 
Questionable poliomye- 
lifts 
Typical poliomyelitis 
TABLE  IV. 
Series IV. 
Monkey  Intracerebral inoeulum  Result 
16  Typical poliomyelitis 
17 
18 
19 
Pettit antipoliomyelitis serum .............  O. 9 ce. 
5% suspension poliomyelitis vires .........  0.3 co. 
Pettit antipoliomyelitis serum .............  0.9 cc. 
5% Berkefeld filtrate poli0melitis virus  .....  0.3 cc. 
Pettit anfipoliomyelitis serum .............  0.9 cc. 
5% Berkefeld filtrate poliomyelitis virus ....  0.3 cc. 
Normal horse serum ......................  0.9 cc. 
5% Berkefeld filtrate poliomyelitis virus  ....  0.3 cc. 
Questionable  symptoms 
only.  No paralysis 
Typical poliomyelitis 
Poliomyditis (excite- 
ment,  fatigue,  promi- 
nent  facial  paralysis 
only) 
Following these experiments,  we determined  to prepare  sheep  sera  according 
to the method of PettAt.  Three sheep were used.  Previous to the first inoculation, 
the sera of these animals were tested for virus  neutralization in monkeys.  The 
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TABLE  V. 
Series  V. 
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Monkey  Intracerebral inoculum  Result 
20 
21 
22 
23 
24 
Normal serum Sheep I ....................  0.9 ce. 
5% Berkefeld filtrate poliomyelitis virus 1965 
and 1983 ..............................  0.3 cc. 
Normal serum Sheep I ....................  0.9 cc. 
5% suspension poliomyelitis virus 1993 .....  0.3 cc. 
Normal serum Sheep II ...................  0.9 cc. 
5%  Berkefeld  filtrate  poliomyelitis  virus 
1965 and 1983 .........................  0.3 cc. 
Normal serum Sheep III ..................  0.9 cc. 
5%  Berkefeld  filtrate  poliomyelitis  virus 
1993 .................................  0.3 cc. 
Normal monkey serum  ...................  0.9 cc. 
5% suspension poliomyelitis virus  ..........  0.3 co. 
Remained well 
Typical poliomyelitis 
Typical poliomyelitis 
Remained well 
Typical poliomyelitis 
TABLE  VI. 
Series  VI. 
Monke  Intracerebral inoculum  Result 
25  Remained well 
26 
27 
28 
29 
Normal serum Sheep II ...................  0.9 cc. 
5% suspension poliomyelitis virus  ..........  0.3 cc. 
"Immune" serum Sheep II ................  0.9 cc. 
5% suspension poliomyelitis virus  ..........  0.3 cc. 
Normal serum Sheep III ..................  0.9 cc. 
5% suspension poliomyelitis virus ..........  0.5 cc. 
"ImmUne" serum Sheep HI ...............  0.9  cc. 
5%  suspension poliomyelitis virus .........  0.5  cc. 
5% suspension poliomyelitis virus  ..........  0.3 cc. 
Typical poliomyelitis 
Remained well 
Typical poliomyelitis 
Typical poliomyelitis 
Thus it would appear that Sheep I  serum, previous to any immun- 
ization, inhibited  Berkefeld filtrate once and  at  another  time  failed 
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Berkefeld filtrate;  that  Sheep III serum inhibited Berkefeld filtrate. 
Sheep I  was lost from intercurrent  disease.  Sheep II and  III were 
given twenty-one biweekly, intravenous injections, each consisting of 
5 cc. of 5 per cent virus suspension from fresh or glycerolated monkey 
spinal cords.  The animals were bled after a  brief rest, and the sera 
were again tested for neutralization  or inhibition. 
The lack of consistency in results is well shown by the fact that both 
normal sera inhibited or neutralized virus, whereas sera from the same 
animals  after "immunization" failed to do so. 
CONCLUSIONS. 
1. The Rosenow antistreptococcic poliomyelitis serum concentrated 
or  unconcentrated  does not  neutralize  the  virus  of poliomyelitis as 
tested in monkeys. 
2.  The  Pettit antipoliomyelitis  horse  serum  neutralizes  the virus 
only occasionally. 
3.  "Immune" sheep sera prepared according to  the method of Pet- 
tit have not neutralized  virus even when the normal sera of the same 
animal have given neutralization. 
4.  The reason for such chance neutralizations is obscure and should 
not be confused with  the constant  virus-neutralizing  action of both 
human and monkey convalescent sera. 
5.  Experimental evidence affords no basis for the  use of either the 
Rosenow or the Pettit serum in the therapy of poliomyelitis. 
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